Orion OYJ Unsponsored ADR (OTCMKTS:ORINY - Get Free Report) shares traded down 1.2% on Wednesday . The company traded as low as $37.09 and last traded at $37.09. 124 shares changed hands during mid-day trading, a decline of 14% from the average session volume of 144 shares. The stock had previously closed at $37.53.
Orion OYJ Price Performance
The company has a market cap of $10.49 billion, a price-to-earnings ratio of 28.38 and a beta of 0.07. The company has a quick ratio of 2.27, a current ratio of 3.79 and a debt-to-equity ratio of 0.27. The company's fifty day moving average price is $33.17 and its two-hundred day moving average price is $28.78.
Orion OYJ (OTCMKTS:ORINY - Get Free Report) last released its earnings results on Wednesday, April 23rd. The company reported $0.23 EPS for the quarter. Orion OYJ had a return on equity of 36.23% and a net margin of 21.74%. The firm had revenue of $373.03 million for the quarter. On average, equities research analysts forecast that Orion OYJ Unsponsored ADR will post 1.18 EPS for the current fiscal year.
Orion OYJ Company Profile
(
Get Free Report)
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.
Featured Articles
Before you consider Orion OYJ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Orion OYJ wasn't on the list.
While Orion OYJ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
